GLP-1 use among US adolescents surges, but long-term health effects remain unknown
A study reveals that GLP-1 weight loss medication use among teenagers and young adults in the US has rapidly increased in recent years. Long-term effects from using these drugs are still unknown, especially on this young population going through a significant physical development period. Between 2022 and 2026, GLP-1 use among people aged 13–25 seeking obesity treatment increased from 88.2% to 96.1% and outpaced metabolic and bariatric surgery (MBS) use, which saw a decline from 11.6% to 3.7%.This Technical Paper is brought to you by Balchem.
By adding value through price optimization, formulation advantages, and additional health benefits, blending whey protein with premium, science-based collagen peptides such as Peptan® or Nextida® GC holds the potential to be a game-changer. Whether you are developing sports nutrition beverages, functional foods, or holistic health supplements, this session will reveal how leveraging this dynamic mix can help your products stand out on the shelf.
At the IFT FIRST 2026 trade show in Chicago, US, Nexira’s product manager, Charlotte Wallart, introduced the company’s expanded botanical ingredient portfolio for functional beverages. In response to a growing demand for functional mushrooms in Europe, Nexira added lion’s mane, reishi, and maitake extracts to this range. Wallart linked these mushrooms to different health benefits, such as focus, cognition, immunity, vitality, and emotional balance.
Settings
- Play Interval
- Slide Duration
- Thumbnail Bar Position

Latest headlines

Gut friendly fiber Jul 2026

Cognitive supplement trendsJul 2026
Multimedia
At the IFT FIRST 2026 trade show in Chicago, US, Nexira’s product manager, Charlotte Wallart, introduced the company’s expanded botanical ingredient portfolio for functional beverages. In response to a growing demand for functional mushrooms in Europe, Nexira added lion’s mane, reishi, and...
Upcoming webinars

The science of HMOs – A novonesis webinar featuring new clinical findings and ESPGHAN highlights
Novonesis

From boosters to companions: GLP-1 in Food, Beverages and Supplements
Rousselot

Top Nutrition Trends 2027
Nutrition Insight





























